Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

BASF Sells Plant To India's Dr. Reddy's

May 5, 2008 | A version of this story appeared in Volume 86, Issue 18

BASF has agreed to sell a finished pharmaceutical plant in Shreveport, La., to Dr. Reddy's Laboratories for an undisclosed sum. The plant employs about 150 people in the production of drug liquids, tablets, and creams for the North American market. BASF says it wants to concentrate its pharmaceutical activities on excipients, custom synthesis, and active ingredients. Dow Chemical recently sold its British active ingredient facilities to Dr. Reddy's.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.